0

COMTAN از شرکت ORION PHARMA

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

COMTAN از شرکت ORION PHARMA

New Drug Application (NDA): 020796

Company: ORION PHARMA

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
COMTAN ENTACAPONE 200MG TABLET;ORAL Prescription

AB

Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
10/19/1999 ORIG-1 Approval

Type 1 – New Molecular Entity

STANDARD

Label (PDF)

Letter (PDF)

Review

https://www.accessdata.fda.gov/drugsatfda_docs/label/1999/20796LBL.PDF
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/1999/20796LTR.PDF
https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/20796_Comtan.cfm

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
02/22/2016 SUPPL-26 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020796s026lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/020796Orig1s026,021485Orig1s033ltr.pdf

10/16/2015 SUPPL-25 Manufacturing (CMC)

Label is not available on this site.

01/16/2015 SUPPL-24 Labeling-Container/Carton Labels

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020796s024lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020796Orig1s024ltr.pdf

10/11/2013 SUPPL-22 Manufacturing (CMC)

Label is not available on this site.

01/16/2014 SUPPL-21 Manufacturing (CMC)

Label is not available on this site.

06/13/2014 SUPPL-16 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020796s016lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/020796Orig1s016ltr.pdf

10/11/2010 SUPPL-15 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020796s015lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020796s015,021485s020ltr.pdf

02/02/2009 SUPPL-13 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020796s012s013lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020796s012,020796s013ltr.pdf

02/02/2009 SUPPL-12 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020796s012s013lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020796s012,020796s013ltr.pdf

04/18/2002 SUPPL-4 Manufacturing (CMC)-Packaging

Label is not available on this site.

01/17/2002 SUPPL-3 Manufacturing (CMC)-Packaging

Label is not available on this site.

01/10/2002 SUPPL-2 Manufacturing (CMC)

Label is not available on this site.

08/14/2001 SUPPL-1 Manufacturing (CMC)-Control

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
02/22/2016 SUPPL-26

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020796s026lbl.pdf
01/16/2015 SUPPL-24

Labeling-Container/Carton Labels

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020796s024lbl.pdf
06/13/2014 SUPPL-16

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020796s016lbl.pdf
10/11/2010 SUPPL-15

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020796s015lbl.pdf
02/02/2009 SUPPL-13

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020796s012s013lbl.pdf
02/02/2009 SUPPL-12

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020796s012s013lbl.pdf
10/19/1999 ORIG-1 Approval

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/1999/20796LBL.PDF

COMTAN

TABLET;ORAL; 200MG

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
COMTAN ENTACAPONE 200MG TABLET;ORAL Prescription Yes AB 020796 ORION PHARMA
ENTACAPONE ENTACAPONE 200MG TABLET;ORAL Prescription No AB 205792 AJANTA PHARMA LTD
ENTACAPONE ENTACAPONE 200MG TABLET;ORAL Prescription No AB 078941 ATLANTIDE
ENTACAPONE ENTACAPONE 200MG TABLET;ORAL Prescription No AB 203437 AUROBINDO PHARMA LTD
ENTACAPONE ENTACAPONE 200MG TABLET;ORAL Prescription No AB 207210 MACLEODS PHARMS LTD
ENTACAPONE ENTACAPONE 200MG TABLET;ORAL Prescription No AB 090690 SUN PHARM
ENTACAPONE ENTACAPONE 200MG TABLET;ORAL Prescription No AB 206669 SUNSHINE
بخوانید  BIVALIRUDIN از شرکت ACCORD HLTHCARE
برچسب‌ها:

نظرات کاربران